•] Shares TALARIS THERAPEUTICS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • May 3rd, 2021 • Talaris Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 3rd, 2021 Company Industry Jurisdiction
TALARIS THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENTDirector Indemnification Agreement • May 3rd, 2021 • Talaris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 3rd, 2021 Company Industry JurisdictionThis Indemnification Agreement (“Agreement”) is made as of [________] by and between Talaris Therapeutics, Inc., a Delaware corporation (the “Company”), and [Director] (“Indemnitee”).